CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 108,234	$ 126,450
Restricted cash	12,470	12,413
Patient accounts receivable	359,359	313,373
Prepaid expenses	20,332	14,639
Other current assets	26,053	30,060
Total current assets	526,448	496,935
Property and equipment, net of accumulated depreciation of $96,056 and $92,422	42,684	41,845
Operating lease right of use assets	88,425	88,939
Goodwill	1,244,679	1,244,679
Intangible assets, net of accumulated amortization of $15,128 and $14,008	101,778	102,675
Other assets	85,857	85,097
Total assets	2,089,871	2,060,170
Current liabilities:
Accounts payable	36,249	28,237
Payroll and employee benefits	131,631	136,835
Accrued expenses	147,464	140,049
Termination fee paid by UnitedHealth Group	106,000	106,000
Current portion of long-term obligations	37,232	36,314
Current portion of operating lease liabilities	26,284	26,286
Total current liabilities	484,860	473,721
Long-term obligations, less current portion	356,080	361,862
Operating lease liabilities, less current portion	62,220	62,751
Deferred income tax liabilities	43,229	40,635
Other long-term obligations	828	1,418
Total liabilities	947,217	940,387
Commitments and Contingencies—Note 7
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,146,546 and 38,131,478 shares issued; 32,676,115 and 32,667,631 shares outstanding	38	38
Additional paid-in capital	795,063	787,177
Treasury stock, at cost, 5,470,431 and 5,463,847 shares of common stock	(469,243)	(468,626)
Retained earnings	762,325	747,925
Total Amedisys, Inc. stockholders’ equity	1,088,183	1,066,514
Noncontrolling interests	54,471	53,269
Total equity	1,142,654	1,119,783
Total liabilities and equity	$ 2,089,871	$ 2,060,170